Induction triplet chemotherapy in patients with rectal adenocarcinoma and synchronous metastases, an AGEO-FFCD study.

Fiche publication

Date publication

décembre 2024

Journal

Clinics and research in hepatology and gastroenterology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr LEPAGE Côme

Tous les auteurs :
Dabout V, Mineur L, Tougeron D, Malicot KL, Gallois C, Phelip JM, Turpin A, Cohen R, Demoustier B, Hautefeuille V, Locher C, Levaché CB, Mitry E, Lecomte T, Brocard F, Hassid D, Porte M, Breysacher G, Lagasse JP, Lepage C, Valéry M, Bachet JB

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39674570

Résumé

The management of synchronous metastatic rectal cancer (SMRC) is complex and multimodal, involving chemotherapy, surgery and/or radiotherapy. The aim of this study was firstly to confirm the efficacy of the induction FOLFIRINOX, and secondly to evaluate the different therapeutic strategies and outcomes of patients.